Q. With reference to the Sugam Portal and CDSCO, which of the following statements is/are correct?
- The Sugam Portal is an online system designed for manufacturers to apply for necessary licenses and approvals from CDSCO.
- This includes clinical trials for vaccines and rDNA-based drugs, which have now been incorporated into the online application system.
- Applications for adding clinical trial sites will be deemed approved if there are no objections for 3 months.
Select the correct option from the codes given below:
Answer:
Only two
Notes:
- The Sugam Portal is an online system designed for manufacturers to apply for necessary licenses and approvals from CDSCO. Correct: The Sugam Portal is an online system designed for manufacturers to apply for necessary licenses and approvals from CDSCO.
- This includes clinical trials for vaccines and rDNA-based drugs, which have now been incorporated into the online application system. Correct: This includes clinical trials for vaccines and rDNA-based drugs, which have now been incorporated into the online application system.
- Applications for adding clinical trial sites will be deemed approved if there are no objections for 3 months. Incorrect: Applications for adding clinical trial sites will be deemed approved if there are no objections within 30 days.